Skip to main content
Have a personal or library account? Click to login
Natural flavonoids as potential multifunctional agents in prevention of diabetic cataract Cover

Natural flavonoids as potential multifunctional agents in prevention of diabetic cataract

Interdisciplinary Toxicology
Volume 4 (2011): Issue 2 (June 2011)
By:   
Open Access
|Jun 2011
References

References

  1. Alexiou P, Pegklidou K, Chatzopoulou M, Nicolaou I, Demopoulos VJ. (2009). Aldose reductase enzyme and its implication to major health problems of the 21(st) century.: 734-752.
    Search in Google Scholar
  2. Amić D, Davidović-Amić D, Beslo D, Rastija V, Lucić B, Trinajstić N. (2007). SAR and QSAR of the antioxidant activity of flavonoids.: 827-845.
    Search in Google Scholar
  3. Arts IC, Sesink AL, Faassen-Peters M, Hollman PC. (2004). The type of sugar moiety is a major determinant of the small intestinal uptake and subsequent biliary excretion of dietary quercetin glycosides.: 841-847.
    Search in Google Scholar
  4. Baynes JW. (1991). Role of oxidative stress in development of complications in diabetes.: 405-12. Review.
    Search in Google Scholar
  5. Baynes JW, Thorpe SR. (1999). Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.: 1-9. Review.
    Search in Google Scholar
  6. Beaulieu LP, Harris CS, Saleem A, Cuerrier A, Haddad PS, Martineau LC, Bennett SA, Arnason JT. (2010). Inhibitory effect of the Cree traditional medicine wiishichimanaanh (Vaccinium vitis-idaea) on advanced glycation end-product formation: identification of active principles.: 741-747.
    Search in Google Scholar
  7. Beyer-Mears A, Farnsworth NP. (1979). Diminished sugar cataractogenesis by quercetin.: 709-716.
    Search in Google Scholar
  8. Bhimanagouda S, Patil GK, Jayaprakasha KN, Chidambara Murthy, Amit Vikram. (2009). Bioactive Compounds: Historical Perspectives, Opportunities, and Challenges.: 8142-8160.
    Search in Google Scholar
  9. Bischoff SC. (2008). Quercetin: potentials in the prevention and therapy of disease.: 733-740.
    Search in Google Scholar
  10. Bockelbrink A, Roll S, Ruether K, Rasch A, Greiner W, Willich SN. (2008). Cataract surgery and the development or progression of age-related macular degeneration: a systematic review.: 359-367.
    Search in Google Scholar
  11. Boots AW, Haenen GRMM, Bast A. (2008). Health effects of quercetin: From antioxidant to nutraceutical.: 325-337.
    Search in Google Scholar
  12. Bors W, Heller W, Michel C, Saran M. (1990). Flavonoids as antioxidants. Determination of radical-scavanging efficiences. In(Packer L, Glazer AN, Eds.; Academic Press: San Diego CA) vol., pp. 343-355.
    Search in Google Scholar
  13. Bors W, Michel C. (2002). Chemistry of the antioxidant. Effect of polyphenols.: 57-69.
    Search in Google Scholar
  14. Bravo L. (1998). Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance.: 317-333.
    Search in Google Scholar
  15. Brian G, Taylor H. (2001). Cataract blindness - challenges for the 21st century.: 249-256.
    Search in Google Scholar
  16. Bron AJ, Brown NA, Harding JJ, Ganea E. (1998). The lens and cataract in diabetes.: 37-67.
    Search in Google Scholar
  17. Bron AJ, Vrensen GF, Koretz J, Maraini G, Harding JJ. (2000). The ageing lens.: 86-104. Review.
    Search in Google Scholar
  18. Brownlee M. (2000). Negative consequences of glycation.(2 Suppl 1): 9-13.
    Search in Google Scholar
  19. Brownlee M. (2001). Biochemistry and molecular cell biology of diabetic complications.: 813-820.
    Search in Google Scholar
  20. Brownlee M. (2005). The pathobiology of diabetic complications: a unifying mechanism.: 1615-1625.
    Search in Google Scholar
  21. Butkovic V, Klasinc L, Bors W. (2004). Kinetic study of flavonoid reactions with stable radicals.: 2816-2820.
    Search in Google Scholar
  22. Cao G, Sofic E, Prior RL. (1997). Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships.: 749-760.
    Search in Google Scholar
  23. Carbone V, Zhao HT, Chung R, Endo S, Hara A, El-Kabbani O. (2009). Correlation of binding constants and molecular modelling of inhibitors in the active sites of aldose reductase and aldehyde reductase.: 1244-1250.
    Search in Google Scholar
  24. Cervantes-Laurean D, Schramm DD, Jacobson EL, Halaweish I, Bruckner GG, Boissonneault GA. (2006). Inhibition of advanced glycation end product formation on collagen by rutin and its metabolites.: 531-540.
    Search in Google Scholar
  25. Chethan S, Dharmesh SM, Malleshi NG. (2008). Inhibition of aldose reductase from cataracted eye lenses by finger millet (Eleusine coracana) polyphenols.: 10085-10090.
    Search in Google Scholar
  26. Clifford MN. (2004). Diet-derived phenols in plasma and tissues andtheir implications for health.: 1103-14. Review.
    Search in Google Scholar
  27. Costantino L, Rastelli G, Gamberini MC, Vinson JA, Bose P, Iannone A, Staffieri M, Antolini L, Del Corso A, Mura U, Albasini A. (1999). 1-Benzopyran-4-one antioxidants and aldose reductase inhibitors.: 1881-1893.
    Search in Google Scholar
  28. Costantino L, Rastelli G, Gamberini MC, Barlocco D. (2000). Pharmacological approaches to the treatment of diabetic complications.: 1245-1262.
    Search in Google Scholar
  29. Cornish KM, Williamson G, Sanderson J. (2002). Quercetin metabolism in the lens: role in inhibition of hydrogen peroxide induced cataract.: 63-70.
    Search in Google Scholar
  30. Coudert P, Albuisson E, Boire JY, Duroux E, Bastide P, Couquelet J. (1994). Synthesis of pyridazine acetic acid derivatives possessing aldose reductase inhibitory activity and antioxidant properties.: 471-477.
    Search in Google Scholar
  31. Crozier A, Del Rio D, Clifford MN. (2010). Bioavailability of dietary flavonoids and phenolic compounds.: 446-467.
    Search in Google Scholar
  32. Crozier A, Jaganath IB, Clifford MN. (2009). Dietary phenolics: chemistry, bioavailability and effects on health.: 1001-1043. Review.
    Search in Google Scholar
  33. Day AJ, Canada FJ, Diaz JC, Kroon PA, McLauchlan R, Faulds CB, Plumb GW, Morgan MR, Williamson G. (2000). Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase.: 166-170.
    Search in Google Scholar
  34. Day AJ, Dupont MS, Ridley S,(1998). Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver beta-glucosidase activity.: 71-75.
    Search in Google Scholar
  35. Del Corso A, Cappiello M, Mura U. (2008). From a dull enzyme to something else: facts and perspectives regarding aldose reductase.: 1452-1461.
    Search in Google Scholar
  36. Demopoulos VJ, Zaher N, Zika C, Anagnostou C, Mamadou E, Alexiou P, Nicolaou I. (2005). Compounds that combine aldose reductase inhibitory activity and ability to prevent the glycation (glucation and/or fructation) of proteins as putative pharmacotherapeutic agents.: 293-304.
    Search in Google Scholar
  37. Durukan AH, Evereklioglu C, Hurmeric V, Kerimoglu H, Erdurman C, Bayraktar MZ, Mumcuoglu T. (2006). Ingestion of IH636 grape seed proanthocyanidin extract to prevent selenite-induced oxidative stress in experimental cataract.: 1041-1045.
    Search in Google Scholar
  38. El-Kabbani O, Ruiz F, Darmanin C, Chung RP. (2004). Aldose reductase structures: implications for mechanism and inhibition.: 750-762.
    Search in Google Scholar
  39. El-Kabbani O, Podjarny A. (2007). Selectivity determinants of the aldose and aldehyde reductase inhibitor-binding sites.: 1970-1978. Review.
    Search in Google Scholar
  40. Ertekin MV, Koçer I, Karslıoglu I, Taysi S, Gepdiremen A, Sezen O, Balcı E, Bakan N. (2004). Effects of oral ginkgo biloba supplementation on cataract formation and oxidative stress occurring in lenses of rats exposed to total cranium radiotherapy.: 499-502.
    Search in Google Scholar
  41. Fossen T, Pedersen AT, Andersen M. (1998). Flavonoids from red onion (Allium cepa).: 281-285.
    Search in Google Scholar
  42. Gayathri Devi V, Rooban BN, Sasikala V, Sahasranamam V, Abraham A. (2010). Isorhamnetin-3-glucoside alleviates oxidative stress and opacification in selenite cataract in vitro.: 1662-1669.
    Search in Google Scholar
  43. Gee JM, DuPont SM, Day AJ, Plumb GW, Williamson G, Johnson IT. (2000). Intestinal transport of quercetin glycosides in rats involves both deglycosylation and interaction with the hexose transport pathway.: 2765-2771.
    Search in Google Scholar
  44. Giacco F, Brownlee M. (2010). Oxidative stress and diabetic complications.: 1058-1070.
    Search in Google Scholar
  45. Grotte D, Mattox V, Brubaker R. (1985). Fluorescent, physiological and pharmacokinetic properties of fluorescein.: 23-33.
    Search in Google Scholar
  46. Gupta SK, Halder N, Srivastava S, Trivedi D, Joshi S, Varma SD. (2002). Green tea (Camellia sinensis) protects against selenite-induced oxidative stress in experimental cataractogenesis.: 258-263.
    Search in Google Scholar
  47. Gupta SK, Selvan VK, Agrawal SS, Saxena R. (2009). Advances in pharmacological strategies for the prevention of cataract development.: 175-183.
    Search in Google Scholar
  48. Hanasaki Y, Ogawa S, Fukui S. (1994). The correlation between active oxygens scavenging and antioxidative effects of flavonoids.: 845-850.
    Search in Google Scholar
  49. Harding JJ. (2002). Viewing molecular mechanisms of ageing through a lens.: 465-479.
    Search in Google Scholar
  50. Head KA. (2001). Natural therapies for ocular disorders, part two: cataracts and glaucoma.: 141-166. Review.
    Search in Google Scholar
  51. Heim KE, Tagliaferro TR, Bobilya DJ. (2002). Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships.: 572-584.
    Search in Google Scholar
  52. Hightower KR. (1995). The role of the lens epithelium in development of UV cataract.: 71-78.
    Search in Google Scholar
  53. Hollman PCH, Bijsman MNCP, van Gameren Y,(1999). The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man.: 569-573.
    Search in Google Scholar
  54. Huang R, Shi F, Lei T, Song Y, Hughes CL, Liu G. (2007). Effect of the isoflavone genistein against galactose-induced cataracts in rats.: 118-125.
    Search in Google Scholar
  55. Ioku K, Pongpiriyadacha Y, Konishi Y,(1998). Betaglucosidase activity in the rat small intestine toward quercetinmonoglucosides.: 1428-1431.
    Search in Google Scholar
  56. Isai M, Sakthivel M, Ramesh E, Thomas PA, Geraldine P. (2009). Prevention of selenite-induced cataractogenesis by rutin in Wistar rats.: 2570-2577.
    Search in Google Scholar
  57. Jaganath IB, Mullen W, Edwards CA, Crozier A. (2006). The relative contribution of the small and large intestine to the absorption and metabolism of rutin in man.: 1035-1046.
    Search in Google Scholar
  58. Javadzadeh A, Ghorbanihaghjo A, Bonyadi S, Rashidi MR, Mesgari M, Rashtchizadeh N, Argani H. (2009). Preventive effect of onion juice on selenite-induced experimental cataract.: 185-189.
    Search in Google Scholar
  59. Jia Z, Song Z, Zhao Y, Wang X, Liu P. (2011). Grape seed proanthocyanidin extract protects human lens epithelial cells from oxidative stress via reducing NF-κB and MAPK protein expression.: 210-217.
    Search in Google Scholar
  60. Jung SH, Lee YS, Lee S, Lim SS, Kim YS, Shin KH. (2002). Isoflavonoids from the rhizomes of Belamcanda chinensis and their effects on aldose reductase and sorbitol accumulation in streptozotocin induced diabetic rat tissues.: 306-312.
    Search in Google Scholar
  61. Jung HA, Yoon NY, Kang SS, Kim YS, Choi JS. (2008). Inhibitory activities of prenylated flavonoids from Sophora flavescens against aldose reductase and generation of advanced glycation endproducts.: 1227-1236.
    Search in Google Scholar
  62. Jung HA, Jung YJ, Yoon NY, Jeong da M, Bae HJ, Kim DW, Na DH, Choi JS. (2008). Inhibitory effects of Nelumbo nucifera leaves on rat lens aldose reductase, advanced glycation endproducts formation, and oxidative stress.: 3818-3826.
    Search in Google Scholar
  63. Jung HA, Kim YS, Choi JS. (2009). Quantitative HPLC analysis of two key flavonoids and inhibitory activities against aldose reductase from different parts of the Korean thistle, Cirsium maackii.: 2790-2797.
    Search in Google Scholar
  64. Jung HA, Islam MD, Kwon YS, Jin SE, Son YK, Park JJ, Sohn HS, Choi JS. (2011). Extraction and identification of three major aldose reductase inhibitors from Artemisia montana.: 376-384.
    Search in Google Scholar
  65. Kalt W, Hanneken A, Milbury P, Tremblay F. (2010). Recent research on polyphenolics in vision and eye health.: 4001-4007.
    Search in Google Scholar
  66. Kamei A. (1998). Partial properties of four glycosidases in normal human lens and variations in their enzyme activities during aging and with the advance of lens coloration.: 982-986.
    Search in Google Scholar
  67. Kawanishi K, Ueda H, Moriyasu M. (2003). Aldose reductase inhibitors from the nature.: 1353.
    Search in Google Scholar
  68. Kay CD. (2010). The future of flavonoid research.(Suppl 3): S91-S95.
    Search in Google Scholar
  69. Kilic F, Bhardwaj R, Trevithick JR. (1996). Modelling cortical cataractogenesis. XVIII. In vitro diabetic cataract reduction by venoruton. A flavonoid which prevents lens opacification.: 372-378.
    Search in Google Scholar
  70. Kroon PA, Clifford MN, Crozier A, Day AJ, Donovan JL, Manach C, Williamson G. (2004). How should we assess the effects of exposure to dietary polyphenols in vitro?: 15-21.
    Open DOISearch in Google Scholar
  71. Kyselova Z, Stefek M, Bauer V. (2004). Pharmacological prevention of diabetic cataract.: 129-140. Review.
    Search in Google Scholar
  72. Kyselova Z. (2010). Different experimental approaches in modelling cataractogenesis: An overview of selenite-induced nuclear cataract in rats.: 3-14.
    Search in Google Scholar
  73. La Motta C, Sartini S, Mugnaini L, Simorini F, Taliani S, Salerno S, Marini AM, Da Settimo F, Lavecchia A, Novellino E, Cantore M, Failli P, Ciuffi M. (2007). Pyrido[1,2-a]pyrimidin-4-one derivatives as a novel class of selective aldose reductase inhibitors exhibiting antioxidant activity.: 4917-4927.
    Search in Google Scholar
  74. Lee SM, Ko IG, Kim SE, Kim DH, Kang BN. (2010). Protective effect of catechin on apoptosis of the lens epithelium in rats with N-methyl-N-nitrosourea-induced cataracts.: 101-107.
    Search in Google Scholar
  75. Lee YS, Kim SH, Jung SH, Kim JK, Pan CH, Lim SS. (2010). Aldose reductase inhibitory compounds from Glycyrrhiza uralensis.: 917-921.
    Search in Google Scholar
  76. Lija Y, Biju PG, Reeni A, Cibin TR, Sahasranamam V, Abraham A. (2006). Modulation of selenite cataract by the flavonoid fraction of emilia sonchifolia in experimental animal models.: 1091-1095.
    Search in Google Scholar
  77. Lim SS, Jung SH, Ji J, Shin KH, Keum SR. (2001). Synthesis of flavonoids and their effects on aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues.: 653-668.
    Search in Google Scholar
  78. Lu M-P, Wang R, Song X, Chibbar R, Wang X, Wu L, Q Meng QH. (2008). Dietary soy isoflavones increase insulin secretion and prevent the development of diabetic cataracts in streptozotocin-induced diabetic rats.: 464-471.
    Search in Google Scholar
  79. Majumdar S, Srirangam R. (2010). Potential of the bioflavonoids in the prevention/treatment of ocular disorders.: 951-965.
    Search in Google Scholar
  80. Manach C, Williamson G, Morand C, Scalbert A, Remesy C. (2005). Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies.: 2230S-2242S.
    Search in Google Scholar
  81. Matsuda, H, Morikawa T, Toguchida I, Yoshikawa M. (2002). Structural requirements of flavonoids and related compounds for aldose reductase inhibitory activity.: 788-795.
    Search in Google Scholar
  82. Matsuda H, Wang T, Managi H, Yoshikawa M. (2003). Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities.: 5317-5323.
    Search in Google Scholar
  83. Meyer CH, Sekundo W. (2005). Nutritional supplementation to prevent cataract formation.: 103-119.
    Search in Google Scholar
  84. Miean KH, Mohamed S. (2001). Flavonoid (myricetin, quercetin, kaempferol, luteolin and apigenin) content of edible tropical plants.: 3106-1312.
    Search in Google Scholar
  85. Miyamoto S. (2002). Recent advances in aldose reductase inhibitors: potential agents for the treatment of diabetic complications.: 621-631.
    Search in Google Scholar
  86. Mohan M, Gupta SK, Agnihotri S, Joshi S, Uppal RK. (1988). Anticataract action of topical quercetin and myricetin in galactosemic rats.: 685-686.
    Search in Google Scholar
  87. Monnier VM, Cerami A. (1981). Nonenzymatic browning in vivo: possible process for aging of long-lived proteins.: 491-493.
    Search in Google Scholar
  88. Monnier VM, Sell DR, Genuth S. (2005). Glycation products as markers and predictors of the progression of diabetic complications.: 567-581.
    Search in Google Scholar
  89. Morand C, Crespy V, Manach C, Besson C, Demigne C, Remesy C. (1998). Plasma metabolites of quercetin and their antioxidant properties.: R212-R219.
    Search in Google Scholar
  90. Morimitsu Y, Yoshida K, Esaki S, Hirota A. (1995). Protein glycation inhibitors from thyme (Thymus vulgaris).: 2018-2021.
    Search in Google Scholar
  91. Mullen W, Edwards CA, Crozier A. (2006). Absorption, excretion and metabolic profiling of methyl-, glucuronyl- glucosyl and sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions.: 107-116.
    Search in Google Scholar
  92. Nagao A, Seki M, Kobayashi H. (1999). Inhibition of xanthine oxidase by flavonoids.: 1787-1790.
    Search in Google Scholar
  93. Nagaraj RH, Linetsky M, Stitt AW. (2010). The pathogenic role of Maillard reaction in the aging eye.Oct 21. [Epub ahead of print]
    Search in Google Scholar
  94. Nagasawa T, Tabata N, Ito Y, Nishizawa N, Aiba Y, Kitts DD. (2003). Inhibition of glycation reaction in tissue protein incubations by water soluble rutin derivative.: 3-10.
    Search in Google Scholar
  95. Nagasawa T, Tabata N, Ito Y, Aiba Y, Nishizawa N, Kitts DD. (2003). Dietary G-rutin suppresses glycation in tissue proteins of streptozotocin-induced diabetic rats.: 141-147.
    Search in Google Scholar
  96. Nakai N, Fujii Y, Kobashi K, Nomura K. (1985). Aldose reductase inhibitors: flavonoids, alkaloids, acetophenones, benzophenones, and pirohydantoins of chroman.: 491-496.
    Search in Google Scholar
  97. Nakano M, Orimo N, Katagiri N, Tsubata M, Takahashi J, Van Chuyen N. (2008). Inhibitory effect of astraxanthin combined with Flavangenol on oxidative stress biomarkers in streptozotocin-induced diabetic rats.: 175-182.
    Search in Google Scholar
  98. Nijveldt RJ, van Nood E, van Hoorn DEC, Boelens PG, van Norren K, van Leeuwen PAM. (2001). Flavonoids: a review of probable mechanisms of action and potential applications.: 418.
    Search in Google Scholar
  99. Obrosova IG, Chung SS, Kador PF. (2010). Diabetic cataracts: mechanisms and management.: 172-180.
    Search in Google Scholar
  100. Okuda J, Miwa I, Inagaki K, Horie T, Nakayama M. (1982). Inhibition of aldose reductases from rat and bovine lenses by flavonoids.: 3807-3822.
    Search in Google Scholar
  101. Olson RJ, Mamalis N, Werner L, Apple DJ. (2003). Cataract treatment in the beginning of the 21st century.: 146-154.
    Search in Google Scholar
  102. Orhan H, Marol S, Hepsen IF, Sahin G. (1999). Effects of some probable antioxidants on selenite-induced cataract formation and oxidative stress-related parameters in rats.: 219-232.
    Search in Google Scholar
  103. Pashikanti S, de Alba DR, Boissonneault GA, Cervantes-Laurean D. (2010). Rutin metabolites: novel inhibitors of nonoxidative advanced glycation end products.: 656-663.
    Search in Google Scholar
  104. Pietta PG. (2000). Flavonoids as antioxidants.: 1035.
    Search in Google Scholar
  105. Pollreisz A, Schmidt-Erfurth U. (2010). Diabetic cataract - pathogenesis, epidemiology and treatment.: 608751.
    Search in Google Scholar
  106. Ramana BV, Raju TN, Kumar VV, Reddy PUM. (2007). Defensive role of quercetin against imbalances of calcium, sodium, and potassium in galactosemic cataract.: 35-41.
    Search in Google Scholar
  107. Rice-Evans, C. (2001). Flavonoid antioxidants.: 797.
    Search in Google Scholar
  108. Rooban BN, Lija Y, Biju PG, Sasikala V, Sahasranamam V, Abrahama A. (2009). Vitex negundo attenuates calpain activation and cataractogenesis in selenite models.: 575-582.
    Search in Google Scholar
  109. Rooban BN, Sasikala V, Sahasranamam V, Abraham A. (2011). Amelioration of selenite toxicity and cataractogenesis in cultured rat lenses by Vitex negundo.Jan 15. [Epub ahead of print]
    Open DOISearch in Google Scholar
  110. Sanderson J, McLauchlan WR, Williamson G. (1999). Quercetin inhibits hydrogen peroxide-induced oxidation of the rat lens.: 639-645.
    Search in Google Scholar
  111. Scalbert A, Williamson G. (2000). Dietary intake and bioavailability of polyphenols.(8S Suppl): 2073S-2085S.
    Search in Google Scholar
  112. Scalbert A, Morand C, Manach C, Rémésy C. (2002). Absorption and metabolism of polyphenols in the gut and impact on health.: 276-282.
    Search in Google Scholar
  113. Shamsi FA, Sharkey E, Creighton D, Nagaraj RH. (2000). Maillard reactions in lens proteins: methylglyoxal-mediated modifications in the rat lens.: 369-380.
    Search in Google Scholar
  114. Sharma KK, Santhoshkumar P. (2009). Lens aging: effects of crystallins.: 1095-1108. Review.
    Search in Google Scholar
  115. Shearer TR, Ma H, Fukiage C, Azuma M. (1997). Selenite nuclear cataract: review of the model.: 8-17.
    Search in Google Scholar
  116. Scheller S, Wilczok T, Imielski S, Krol W, Gabrys J, Shani J. (1990). Free radical scavenging by ethanol extract of propolis.: 461-465.
    Search in Google Scholar
  117. Sperker B, Backman JT, Kroemer HK. (1997). The role of β-glucuronidase in drug disposition and drug targeting in humans.: 18-31.
    Search in Google Scholar
  118. Stefek M, Snirc V, Djoubissie PO, Majekova M, Demopoulos V, Rackova L, Bezakova Z, Karasu C, Carbone V, El-Kabbani O. (2008). Carboxymethylated pyridoindole antioxidants as aldose reductase inhibitors: Synthesis, activity, partitioning, and molecular modeling.: 4908-4920.
    Search in Google Scholar
  119. Stitt AW. (2005). The maillard reaction in eye diseases.: 582-597.
    Search in Google Scholar
  120. Suryanarayana P, Kumar PA, Saraswat M, Petrash JM, Reddy GB. (2004). Inhibition of aldose reductase by tannoid principles of Emblica officinalis: implications for the prevention of sugar cataract.: 148-154.
    Search in Google Scholar
  121. Suzen S, Buyukbingol E. (2003). Recent studies of aldose reductase enzyme inhibition for diabetic complications.: 1329-1352.
    Search in Google Scholar
  122. Taylor A. (1993). Cataract: relationship between nutrition and oxidation.: 138-146.
    Search in Google Scholar
  123. Taylor HR. (1999). Epidemiology of age-related cataract.: 445-448.
    Search in Google Scholar
  124. Thiagarajan G, Chandani S, Sundari SC, Harinarayana Rao S, Kulkarni VA, Balasubramanian D. (2001). Antioxidant properties of green and black tea, and their potential ability to retard the progression of eye lens cataract.: 393-401.
    Search in Google Scholar
  125. Thiagarajan G, Chandani S, Harinarayana Rao S, Samuni AM, Chandrasekaran K, Balasubramanian D. (2002). Molecular and cellular assessment of Ginkgo biloba extract as a possible ophthalmic drug.: 421-430.
    Search in Google Scholar
  126. Thornalley PJ. (2005). Dicarbonyl intermediates in the Maillard reaction.: 111-117.
    Search in Google Scholar
  127. Thorpe SR, Baynes JW. (1996). Role of the Maillard reaction in diabetes mellitus and diseases of aging.: 69-77.
    Search in Google Scholar
  128. Turk Z. (2010). Glycotoxines, carbonyl stress and relevance to diabetes and its complications.: 147-156.
    Search in Google Scholar
  129. Urios P, Grigorova-Borsos AM, Sternberg M. (2007). Flavonoids inhibit the formation of the cross-linking AGE pentosidine in collagen incubated with glucose, according to their structure.: 139-146.
    Search in Google Scholar
  130. Varma SD, Kinoshita JH. (1976). Inhibition of lens aldose reductase by flavonoids - their possible role in the prevention of diabetic cataracts.: 2505-2513.
    Search in Google Scholar
  131. Varma SD, Mikuni I, Kinoshita JH. (1975). Flavonoids as inhibitors of lens aldose reductase.: 1215-1216.
    Search in Google Scholar
  132. Varma SD, Mizuno A, Kinoshita JH. (1977). Diabetic Cataracts and Flavonoids.: 205-206.
    Search in Google Scholar
  133. Vibin M, Siva Priya SG, N Rooban B, Sasikala V, Sahasranamam V, Abraham A. (2010). Broccoli regulates protein alterations and cataractogenesis in selenite models.: 99-107.
    Search in Google Scholar
  134. Walle T. (2004). Absorption and metabolism of flavonoids.: 829-837. Review.
    Search in Google Scholar
  135. Weinreb RN, Jeng S, Miller AL. (1991). Lysosomal enzyme activity in human aqueous humor.: 1-6.
    Search in Google Scholar
  136. Williamson G, Manach C. (2005). Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies.(1 Suppl): 243S-255S. Review.
    Search in Google Scholar
  137. Williams RJ, Spencer JP, Rice-Evans C. (2004). Flavonoids: antioxidants or signalling molecules?: 838-849.
    Open DOISearch in Google Scholar
  138. Wirasathien L, Pengsuparp T, Suttisri R, Ueda H, Moriyasu M, Kawanishi K. (2007). Inhibitors of aldose reductase and advanced glycation end-products formation from the leaves of Stelechocarpus cauliflorus R.E. Fr.: 546-550.
    Search in Google Scholar
  139. Wu CH, Yen GC. (2005). Inhibitory effect of naturally occurring flavonoids on the formation of advanced glycation endproducts.: 3167-3173.
    Search in Google Scholar
  140. Yao K, Zhang L, Zhang Y, Ye P, Zhu N. (2008). The flavonoid fisetin inhibits UV radiation-induced oxidative stress and the activation of NF-kappaB and MAPK signaling in human lens epithelial cells.: 1865-1871.
    Search in Google Scholar
  141. Yabe-Nishimura C. (1998). Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications.: 21-33.
    Search in Google Scholar
DOI: https://doi.org/10.2478/v10102-011-0013-y | Journal eISSN: 1337-9569 | Journal ISSN: 1337-6853
Journal RSS Feed
Language: English
Page range: 69 - 77
Published on: Jun 17, 2011
Published by: Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
In partnership with: Paradigm Publishing Services
Keywords:
diabetic cataract,
natural flavonoids,
oxidative stress,
antioxidans,
aldose reductase inhibitors,
glycation inhibitors
Related subjects:
Medicine,
Clinical medicine,
Pharmacology, toxicology

© 2011 Milan Stefek, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons License.

Volume 4 (2011): Issue 2 (June 2011)
Previous article
Next article